Advanced Therapy Medicinal Product (ATMP) Market  Size, Share, Industry, Forecast and Outlook (2024-2031)

Advanced Therapy Medicinal Product (ATMP) Market Size, Share, Industry, Forecast and Outlook (2024-2031)

<h2>Global Advanced Therapy Medicinal Product(ATMP) Market is Segmented By Type (Gene Therapy Medicines, Somatic Cell Therapy Medicines, Tissue Engineered Medicines), By Disease Indication (Cancer, Cardiovascular diseases, Musculoskeletal, Immune System and Inflammation, Neurology, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2024-2031</h2>

<h3>Advanced Therapy Medicinal Product(ATMP) Market Overview</h3>

<blockquote>
Global Advanced Therapy Medicinal Product(ATMP) Market reached US$ YY&nbsp;million in 2023&nbsp;and is expected to reach US$ YY&nbsp;million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.
</blockquote>

<a href="https://msbs-dmi-img.s3.eu-west-2.amazonaws.com/bucketFolder/1702639625206-lg.png" target="_blank"><img alt="Global Advanced Therapy Medicinal Product(ATMP) Market 2021-2030" src="https://msbs-dmi-img.s3.eu-west-2.amazonaws.com/bucketFolder/1702639625206-lg.png" style="height:640px; width:853px" /></a>

Advanced therapy medicinal products (ATMPs) are medicines that are produced based on genes, tissues, or cells. They offer new opportunities for the treatment of disease and injury. The ATMPs are classified into gene therapy medicines, somatic cell therapy medicines, and tissue-engineered medicines.&nbsp;

Advanced therapy medicinal products (ATMPs) constitute an innovative class of heterogeneous research-driven biopharmaceuticals. The drugs are based on cell therapy and gene therapy, the therapies in combination with medical devices are called tissue-engineered products.&nbsp;

<h3>Advanced Therapy Medicinal Product(ATMP) Market Scope</h3>

<table cellspacing="0" style="border-collapse:collapse">
	<tbody>
		<tr>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #4472c4; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Metrics
			</td>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-right:1px solid #4472c4; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Details
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			CAGR
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			YY%
			</td>
		</tr>
		<tr>
			<td style="border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Market Size&nbsp;
			</td>
			<td style="border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2022-2031
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Market Estimation Forecast Period
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2024-2031
			</td>
		</tr>
		<tr>
			<td style="border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Revenue Units
			</td>
			<td style="border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Value (US$ Mn)&nbsp;
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Segments Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Type, Disease Indication
			</td>
		</tr>
		<tr>
			<td style="border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Regions Covered
			</td>
			<td style="border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America, Europe, Asia-Pacific, South America, and Middle East &amp; Africa
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:top; width:312px">
			Largest Region
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:top; width:312px">
			North America
			</td>
		</tr>
		<tr>
			<td style="border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Fastest Growing Region
			</td>
			<td style="border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Asia-Pacific
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Report Insights Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter&rsquo;s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Other key Insights.
			</td>
		</tr>
	</tbody>
</table>

&nbsp;

For more details on this report &ndash; <a href="https://www.datamintelligence.com/download-sample/advanced-therapy-medicinal-product-atmp-market" target="_blank">Request for Sample</a>

&nbsp;

<h3>Market Dynamics: Drivers &amp; Restraints</h3>

The increase in the number of research and developmental activities&nbsp;

The increase in the novel approaches to treating genetic disorders and increased investments in the research for developing new drugs and treatment procedures is expected to drive the market growth.&nbsp;

For instance, according to the National Center for Science and Engineering Statistics, it is estimated that Research and development spending by academic institutions totaled $97.8 billion in 2022, an increase of $8.0 billion from 2021

For instance, Urgo launched a $107M artificial skin engineering laboratory novel tissue engineering laboratory to create artificial skin to help the health care professionals in the effective treatment of severe wounds and quickly curing patients. Thus, the increasing research and increase in investments in introducing new products are expected to drive market growth in the forecast period.

Stringent regulations for the approvals

The stringent regulations associated with the approvals of the medicine are expected to decline the market growth. The risks associated with gene corrections and treatments are also a factor that hamper market growth.

<h3>Advanced Therapy Medicinal Product(ATMP) Market Segmentation</h3>

The global advanced therapy medicinal product (ATMP) market is segmented based on type, disease indication, and region.

<a href="https://msbs-dmi-img.s3.eu-west-2.amazonaws.com/bucketFolder/1702639664634-lg.png" target="_blank"><img alt="Advanced Therapy Medicinal Product(ATMP) Market Segmentation Value 2023" src="https://msbs-dmi-img.s3.eu-west-2.amazonaws.com/bucketFolder/1702639664634-lg.png" style="height:640px; width:853px" /></a>

Gene therapy medicines segment accounted for 49.5% of the market share&nbsp;

Gene therapy medicines have been holding a dominant position in the market share. This is due to the increase in genetic disorders and also the efficiency of the treatment to treat the disorder. Gene therapy drugs such as siRNA, shRNA, antisense oligonucleotide, CRISPR/Cas9 system, plasmid DNA, and miRNA have shown great potential in biomedical applications.

Gene therapy is a new generation of medicine where a functioning gene is delivered to a targeted tissue in the body to produce a missing or nonfunctioning protein. Based on the cells and genes of the individual the medicines that target the incorrect gene are produced. Most of the disease conditions can be cured or prevented by gene therapy medicine.&nbsp;

For instance, according to the NIH report in 2021, it is estimated that genetic therapy medicine management showed 30&ndash;40% complete response and 50&ndash;60% partial response with a total response rate of 90%&ndash;96% in different therapeutic uses. Thus, the above factors are expected to hold the segment in the dominant market share.

<h3>Geographical Analysis</h3>

North America is expected to hold a significant position in the global advanced therapy medicinal product (ATMP) market share

North America is expected to hold a dominant position in the market share due to the increase in genetic disorders. An increase in genetic disorders in the region is boosting research and paving the way for the development of new drugs.&nbsp;

For instance, According to the CDC report in 2022, Cystic fibrosis (CF) is a genetic disorder that causes problems with breathing and digestion. CF affects about 35,000 people in the United States. Approximately 1,000 new cases of CF are diagnosed each year in the U.S.&nbsp;

Additionally, researchers estimated that 18,000 males in the United States had hemophilia. Additionally, about two-thirds of these individuals received care in the U.S. network of specialized and comprehensive Hemophilia Treatment Centers (HTCs). Thus, the above factors are expected to drive the region&rsquo;s market growth in the forecast period.&nbsp;

<a href="https://msbs-dmi-img.s3.eu-west-2.amazonaws.com/bucketFolder/1702639734405-lg.png" target="_blank"><img alt="North America Advanced Therapy Medicinal Product(ATMP) Market Share 2023-2030" src="https://msbs-dmi-img.s3.eu-west-2.amazonaws.com/bucketFolder/1702639734405-lg.png" style="height:640px; width:853px" /></a>

<h3>COVID-19 Impact Analysis</h3>

COVID-19 has had a moderate impact on the growth of the market. The R&amp;D activities have been reduced during the COVID-19, this is due to the shift of the interest and need of the introduction of new drugs for the treatment of COVID-19. The supply chains have been interrupted during the lockdown period.

<a href="https://msbs-dmi-img.s3.eu-west-2.amazonaws.com/bucketFolder/1702639784058-lg.png" target="_blank"><img alt="Impact Analysis" src="https://msbs-dmi-img.s3.eu-west-2.amazonaws.com/bucketFolder/1702639784058-lg.png" style="height:640px; width:853px" /></a>

<h3>Competitive Landscape</h3>

The leading companies with a significant market share include RHEACELL., BioTissue Technologies GmbH, Mukocell GmbH, Orchard Therapeutics plc., Kite Pharma EU B.V., Bristol-Myers Squibb Pharma EEIG, Novartis Europharm Limited, and Amgen Europe B.V. among others.

Why Purchase the Report?

<ul>
	<li>To visualize the global advanced therapy medicinal product (ATMP) market segmentation based on type, disease indication, and region as well as understand key commercial assets and players.</li>
	<li>Identify commercial opportunities by analyzing trends and co-development.&nbsp;</li>
	<li>Excel data sheet with numerous data points of advanced therapy medicinal product market-level with all segments.</li>
	<li>PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.</li>
	<li>Product mapping available as excel consisting of key products of all the major players.</li>
</ul>

The global advanced therapy medicinal product market report would provide approximately 47 tables, 48 figures, and 176 Pages.

<h3>Target Audience 2024</h3>

<ul>
	<li>Manufacturers/ Buyers</li>
	<li>Industry Investors/Investment Bankers</li>
	<li>Research Professionals</li>
	<li>Emerging Companies</li>
</ul>

<ol>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Definition and Overview</h3>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Executive Summary</h3>

	<ol>
		<li>Snippet by Type</li>
		<li>Snippet by Disease Indication</li>
		<li>Snippet by Region</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Dynamics</h3>

	<ol>
		<li>Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>The increase in the number of research and developmental activities</li>
				<li>XX</li>
			</ol>
			</li>
			<li>Restraints
			<ol>
				<li>Stringent regulations for the approvals</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Industry Analysis&nbsp;</h3>

	<ol>
		<li>Porter&#39;s Five Force Analysis&nbsp;</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Russia-Ukraine War Impact Analysis</li>
		<li>DMI Opinion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">COVID-19 Analysis</h3>

	<ol>
		<li>Analysis of COVID-19
		<ol>
			<li>Scenario Before COVID</li>
			<li>Scenario During COVID</li>
			<li>Scenario Post COVID</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid COVID-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Type</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Type</li>
			<li>Market Attractiveness Index, By Type</li>
		</ol>
		</li>
		<li>Gene Therapy Medicines*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Somatic Cell Therapy Medicines</li>
		<li>Tissue Engineered Medicines</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Disease Indication</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Indication</li>
			<li>Market Attractiveness Index, By Disease Indication</li>
		</ol>
		</li>
		<li>Cancer *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Cardiovascular diseases&nbsp;</li>
		<li>Musculoskeletal&nbsp;</li>
		<li>Immune System and Inflammation</li>
		<li>Neurology&nbsp;</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Region</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Indication&nbsp;</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Indication</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>UK</li>
				<li>France</li>
				<li>Italy</li>
				<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Indication</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia-Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Indication</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia-Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Indication</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Competitive Landscape</h3>

	<ol>
		<li>Competitive Scenario</li>
		<li>Market Positioning/Share Analysis</li>
		<li>Mergers and Acquisitions Analysis</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Company Profiles</h3>

	<ol>
		<li>RHEACELL. *
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Financial Overview</li>
			<li>Key Developments</li>
		</ol>
		</li>
		<li>BioTissue Technologies GmbH</li>
		<li>Mukocell GmbH</li>
		<li>Orchard Therapeutics plc.&nbsp;</li>
		<li>Kite Pharma EU B.V.</li>
		<li>Bristol-Myers Squibb Pharma EEIG</li>
		<li>Novartis Europharm Limited</li>
		<li>Amgen Europe B.V.&nbsp;(*LIST NOT EXHAUSTIVE)&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Appendix</h3>

	<ol>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

&nbsp;

<ul>
</ul>

List of Tables

Table 1 Global Advanced Therapy Medicinal Product (ATMP) Market Value, By Type, 2023, 2027 &amp; 2031 (US$ Million)

Table 2 Global Advanced Therapy Medicinal Product (ATMP) Market Value, By Disease Indication, 2023, 2027 &amp; 2031 (US$ Million)

Table 3 Global Advanced Therapy Medicinal Product (ATMP) Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Million)

Table 4 Global Advanced Therapy Medicinal Product (ATMP) Market Value, By Type, 2023, 2027 &amp; 2031 (US$ Million)

Table 5 Global Advanced Therapy Medicinal Product (ATMP) Market Value, By Type, 2022-2031 (US$ Million)

Table 6 Global Advanced Therapy Medicinal Product (ATMP) Market Value, By Disease Indication, 2023, 2027 &amp; 2031 (US$ Million)

Table 7 Global Advanced Therapy Medicinal Product (ATMP) Market Value, By Disease Indication, 2022-2031 (US$ Million)

Table 8 Global Advanced Therapy Medicinal Product (ATMP) Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Million)

Table 9 Global Advanced Therapy Medicinal Product (ATMP) Market Value, By Region, 2022-2031 (US$ Million)

Table 10 North America Advanced Therapy Medicinal Product (ATMP) Market Value, By Type, 2022-2031 (US$ Million)

Table 11 North America Advanced Therapy Medicinal Product (ATMP) Market Value, By Disease Indication, 2022-2031 (US$ Million)

Table 12 North America Advanced Therapy Medicinal Product (ATMP) Market Value, By Country, 2022-2031 (US$ Million)

Table 13 South America Advanced Therapy Medicinal Product (ATMP) Market Value, By Type, 2022-2031 (US$ Million)

Table 14 South America Advanced Therapy Medicinal Product (ATMP) Market Value, By Disease Indication, 2022-2031 (US$ Million)

Table 15 South America Advanced Therapy Medicinal Product (ATMP) Market Value, By Country, 2022-2031 (US$ Million)

Table 16 Europe Advanced Therapy Medicinal Product (ATMP) Market Value, By Type, 2022-2031 (US$ Million)

Table 17 Europe Advanced Therapy Medicinal Product (ATMP) Market Value, By Disease Indication, 2022-2031 (US$ Million)

Table 18 Europe Advanced Therapy Medicinal Product (ATMP) Market Value, By Country, 2022-2031 (US$ Million)

Table 19 Asia-Pacific Advanced Therapy Medicinal Product (ATMP) Market Value, By Type, 2022-2031 (US$ Million)

Table 20 Asia-Pacific Advanced Therapy Medicinal Product (ATMP) Market Value, By Disease Indication, 2022-2031 (US$ Million)

Table 21 Asia-Pacific Advanced Therapy Medicinal Product (ATMP) Market Value, By Country, 2022-2031 (US$ Million)

Table 22 Middle East &amp; Africa Advanced Therapy Medicinal Product (ATMP) Market Value, By Type, 2022-2031 (US$ Million)

Table 23 Middle East &amp; Africa Advanced Therapy Medicinal Product (ATMP) Market Value, By Disease Indication, 2022-2031 (US$ Million)

Table 24 RHEACELL.: Overview

Table 25 RHEACELL.: Product Portfolio

Table 26 RHEACELL.: Key Developments

Table 27 BioTissue Technologies GmbH: Overview

Table 28 BioTissue Technologies GmbH: Product Portfolio

Table 29 BioTissue Technologies GmbH: Key Developments

Table 30 Mukocell GmbH: Overview

Table 31 Mukocell GmbH: Product Portfolio

Table 32 Mukocell GmbH: Key Developments

Table 33 Orchard Therapeutics plc.: Overview

Table 34 Orchard Therapeutics plc.: Product Portfolio

Table 35 Orchard Therapeutics plc.: Key Developments

Table 36 Kite Pharma EU B.V.: Overview

Table 37 Kite Pharma EU B.V.: Product Portfolio

Table 38 Kite Pharma EU B.V.: Key Developments

Table 39 Bristol-Myers Squibb Pharma EEIG: Overview

Table 40 Bristol-Myers Squibb Pharma EEIG: Product Portfolio

Table 41 Bristol-Myers Squibb Pharma EEIG: Key Developments

Table 42 Novartis Europharm Limited: Overview

Table 43 Novartis Europharm Limited: Product Portfolio

Table 44 Novartis Europharm Limited: Key Developments

Table 45 Amgen Europe B.V.: Overview

Table 46 Amgen Europe B.V.: Product Portfolio

Table 47 Amgen Europe B.V.: Key Developments

List of Figures

Figure 1 Global Advanced Therapy Medicinal Product (ATMP) Market Value, 2022-2031 (US$ Million)

Figure 2 Global Advanced Therapy Medicinal Product (ATMP) Market Share, By Type, 2022 &amp; 2031 (%)

Figure 3 Global Advanced Therapy Medicinal Product (ATMP) Market Share, By Disease Indication, 2022 &amp; 2031 (%)

Figure 4 Global Advanced Therapy Medicinal Product (ATMP) Market Share, By Region, 2022 &amp; 2031 (%)

Figure 5 Global Advanced Therapy Medicinal Product (ATMP) Market Y-o-Y Growth, By Type, 2022-2031 (%)

Figure 6 Gene Therapy Medicines Advanced Therapy Medicinal Product (ATMP) Market Value, 2022-2031 (US$ Million)

Figure 7 Somatic Cell Therapy Medicines Advanced Therapy Medicinal Product (ATMP) Market Value, 2022-2031 (US$ Million)

Figure 8 Tissue Engineered Medicines Advanced Therapy Medicinal Product (ATMP) Market Value, 2022-2031 (US$ Million)

Figure 9 Global Advanced Therapy Medicinal Product (ATMP) Market Y-o-Y Growth, By Disease Indication, 2022-2031 (%)

Figure 10 Cancer Disease Indication in Global Advanced Therapy Medicinal Product (ATMP) Market Value, 2022-2031 (US$ Million)

Figure 11 Cardiovascular diseases Disease Indication in Global Advanced Therapy Medicinal Product (ATMP) Market Value, 2022-2031 (US$ Million)

Figure 12 Musculoskeletal Disease Indication in Global Advanced Therapy Medicinal Product (ATMP) Market Value, 2022-2031 (US$ Million)

Figure 13 Immune System and Inflammation Disease Indication in Global Advanced Therapy Medicinal Product (ATMP) Market Value, 2022-2031 (US$ Million)

Figure 14 Neurology Disease Indication in Global Advanced Therapy Medicinal Product (ATMP) Market Value, 2022-2031 (US$ Million)

Figure 15 Others Disease Indication in Global Advanced Therapy Medicinal Product (ATMP) Market Value, 2022-2031 (US$ Million)

Figure 16 Global Advanced Therapy Medicinal Product (ATMP) Market Y-o-Y Growth, By Region, 2022-2031 (%)

Figure 17 North America Advanced Therapy Medicinal Product (ATMP) Market Value, 2022-2031 (US$ Million)

Figure 18 Asia-Pacific Advanced Therapy Medicinal Product (ATMP) Market Value, 2022-2031 (US$ Million)

Figure 19 Europe Advanced Therapy Medicinal Product (ATMP) Market Value, 2022-2031 (US$ Million)

Figure 20 South America Advanced Therapy Medicinal Product (ATMP) Market Value, 2022-2031 (US$ Million)

Figure 21 Middle East and Africa Advanced Therapy Medicinal Product (ATMP) Market Value, 2022-2031 (US$ Million)

Figure 22 North America Advanced Therapy Medicinal Product (ATMP) Market Value, 2022-2031 (US$ Million)

Figure 23 North America Advanced Therapy Medicinal Product (ATMP) Market Share, By Type, 2022 &amp; 2031 (%)

Figure 24 North America Advanced Therapy Medicinal Product (ATMP) Market Share, By Disease Indication, 2022 &amp; 2031 (%)

Figure 25 North America Advanced Therapy Medicinal Product (ATMP) Market Share, By Country, 2022 &amp; 2031 (%)

Figure 26 South America Advanced Therapy Medicinal Product (ATMP) Market Value, 2022-2031 (US$ Million)

Figure 27 South America Advanced Therapy Medicinal Product (ATMP) Market Share, By Type, 2022 &amp; 2031 (%)

Figure 28 South America Advanced Therapy Medicinal Product (ATMP) Market Share, By Disease Indication, 2022 &amp; 2031 (%)

Figure 29 South America Advanced Therapy Medicinal Product (ATMP) Market Share, By Country, 2022 &amp; 2031 (%)

Figure 30 Europe Advanced Therapy Medicinal Product (ATMP) Market Value, 2022-2031 (US$ Million)

Figure 31 Europe Advanced Therapy Medicinal Product (ATMP) Market Share, By Type, 2022 &amp; 2031 (%)

Figure 32 Europe Advanced Therapy Medicinal Product (ATMP) Market Share, By Disease Indication, 2022 &amp; 2031 (%)

Figure 33 Europe Advanced Therapy Medicinal Product (ATMP) Market Share, By Country, 2022 &amp; 2031 (%)

Figure 34 Asia-Pacific Advanced Therapy Medicinal Product (ATMP) Market Value, 2022-2031 (US$ Million)

Figure 35 Asia-Pacific Advanced Therapy Medicinal Product (ATMP) Market Share, By Type, 2022 &amp; 2031 (%)

Figure 36 Asia-Pacific Advanced Therapy Medicinal Product (ATMP) Market Share, By Disease Indication, 2022 &amp; 2031 (%)

Figure 37 Asia-Pacific Advanced Therapy Medicinal Product (ATMP) Market Share, By Country, 2022 &amp; 2031 (%)

Figure 38 Middle East &amp; Africa Advanced Therapy Medicinal Product (ATMP) Market Value, 2022-2031 (US$ Million)

Figure 39 Middle East &amp; Africa Advanced Therapy Medicinal Product (ATMP) Market Share, By Type, 2022 &amp; 2031 (%)

Figure 40 Middle East &amp; Africa Advanced Therapy Medicinal Product (ATMP) Market Share, By Disease Indication, 2022 &amp; 2031 (%)

Figure 41 RHEACELL.: Financials

Figure 42 BioTissue Technologies GmbH: Financials

Figure 43 Mukocell GmbH: Financials

Figure 44 Orchard Therapeutics plc.: Financials

Figure 45 Kite Pharma EU B.V.: Financials

Figure 46 Bristol-Myers Squibb Pharma EEIG: Financials

Figure 47 Novartis Europharm Limited: Financials

Figure 48 Amgen Europe B.V.: Financials

 
 
 
 
 
 
&nbsp;

Advanced Therapy Medicinal Product (ATMP) Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Tissue Engineering Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 March 06

Starting from

Gene Therapy Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 January 10

Starting from